Related Experiment Videos
Drug resistance in lung cancer
1Pharmacology Division, National Cancer Center Research Institute, Tokyo, Japan.
Abstract:
The major problem in lung cancer chemotherapy is the emergence of inherent and acquired drug resistance of the cancer cells. Establishment of drug-resistant sublines and comparative investigations of such cell lines with their parental cells to determine their molecular, biologic, and biochemical properties are important research strategies. Genetic changes in tumor cells may induce changes in their biochemical properties and chemosensitivity. Many mechanisms that render tumor cells resistant have been identified, and they have provided new molecular targets for surrogate markers to predict chemosensitivity. The new categories of anticancer drugs, such as topoisomerase I inhibitors and taxanes, and non-cytotoxic new drugs, have been introduced clinically. It is important to define the molecular determinants of resistance to these drugs. The development of an appropriate model for overcoming drug resistance is one of the important issues that should be solved before carrying out further clinical trials.
Insights
Drug resistance in lung cancer chemotherapy is a major challenge. Understanding the molecular mechanisms of resistance is key to developing effective treatments and overcoming this challenge in clinical trials.
Area of Science:
- Oncology
- Cancer Research
- Pharmacology
Background:
- Drug resistance in lung cancer chemotherapy presents a significant obstacle.
- Acquired and inherent resistance in cancer cells necessitates further investigation.
- Understanding resistance mechanisms is crucial for advancing cancer treatment.
Purpose of the Study:
- To explore strategies for establishing and investigating drug-resistant cancer cell lines.
- To identify molecular determinants of resistance to novel anticancer drugs.
- To develop models for overcoming drug resistance in lung cancer.
Main Methods:
- Establishment of drug-resistant sublines.
- Comparative analysis of resistant and parental cell lines.
- Investigation of molecular, biologic, and biochemical properties.
Main Results:
- Genetic alterations in tumor cells correlate with biochemical property changes and chemosensitivity.
- Identified mechanisms of tumor cell resistance offer potential molecular targets.
- New anticancer drugs like topoisomerase I inhibitors and taxanes require defined resistance determinants.
Conclusions:
- Defining molecular determinants of resistance is essential for new drug development.
- Developing effective models to overcome drug resistance is critical for clinical trial progression.
- Further research into drug resistance mechanisms will improve lung cancer chemotherapy outcomes.